SCHEMBL7964110

SCHEMBL7964110

CC(C)(C)c1cc(/C=C(/C#N)S(=O)(=O)Cc2cccc(C(F)(F)F)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ TSHR P16473 3/20 0.43
▸ BLM P54132 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ HIF1A Q16665 3/20 0.43
▸ RGS12 O14924 2/20 0.43
▸ GMNN O75496 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964107 1.00 MAPT (0.43) MAPTMEN1CYP3A4TSHRBLM
SCHEMBL7964113 1.00 MAPT (0.43) MAPTMEN1CYP3A4TSHRBLM
SCHEMBL7963384 0.88 LMNA (0.38) MAPTLMNARAB9AGAAEGFR
SCHEMBL7963391 0.88 LMNA (0.38) MAPTLMNARAB9AGAAEGFR
SCHEMBL7963389 0.88 LMNA (0.38) MAPTLMNARAB9AGAAEGFR
SCHEMBL7964271 0.85 MAPT (0.42) MAPTSMN1; SMN2LMNAALDH1A1TP53
SCHEMBL7964275 0.85 MAPT (0.42) MAPTSMN1; SMN2LMNAALDH1A1TP53
SCHEMBL7964269 0.85 MAPT (0.42) MAPTSMN1; SMN2LMNAALDH1A1TP53
SCHEMBL7952698 0.83 EGFR (0.55) MAPTMEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL7952691 0.83 EGFR (0.55) MAPTMEN1KMT2ASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 — — US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US disclosed
Send feedback